Comparing the Performance of a Categorical Loudness Scaling Based Fitting With a Behavioural Fitting in Adults With a Nucleus Cochlear Implant 3 Months Post-activation
- Conditions
- Hearing Loss
- Interventions
- Device: Categorical loudness scaling based fitting using the Nexus Research System.Device: Behavioural fitting using Custom Sound Suite (CSS 6.3) Software
- Registration Number
- NCT05709223
- Lead Sponsor
- Cochlear
- Brief Summary
This study aims to collect data in newly implanted cochlear implant-recipients to inform future development of fitting methods to optimally and efficiently program a cochlear implant.
- Detailed Description
Firstly, it aims to collect data to investigate if the new fitting method gives a good fit of MAP for newly implanted CI-recipients in terms of performance outcomes, compared to the standard streamlined behavioural fitting after 3 months of use. Secondly, it aims to collect data to further refine the new fitting method beyond what is evaluated within this study.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 17
- Aged 18 years or older (no upper age limit).
- Post-lingually deafened defined as severe or greater sensorineural hearing loss onset after the age of 2 years as reported by the subject
- Unilaterally implanted with the CI600 Series (CI612, CI622, CI632) or CI500 series (CI512, CI522, CI532) cochlear implant.
- Fluent speaker in the language used to assess speech perception performance, as determined by the investigator.
- Willingness to participate in and comply with all requirements of the protocol.
- Willing and able to provide written informed consent
- Score below 3 on the screening subset of questions from the Mobile Device Proficiency Questionnaire.
- Subject who will be programmed with an acoustic component in the implanted ear.
- Pure tone average (average of unaided thresholds at 0.5, 1, 2 and 4 kHz) less than or equal to 30 dB HL and aided word score of more than 80% in the contralateral ear.
- Diagnosis of auditory neuropathy.
- Additional health factors, known to the investigator, that would prevent or restrict participation in the evaluations, including significant visual impairment and/or dexterity issues.
- Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
- Investigator site personnel directly affiliated with this study and/or their immediate families: immediate family is defined as a spouse, parent, child, or sibling.
- Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation.
- Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation). -
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Participants receiving both Categorical Loudness Scaling Based Fitting and behavioural fitting. Behavioural fitting using Custom Sound Suite (CSS 6.3) Software Participants will receive a categorical loudness scaling based fitting (Interventional) and behavioural fitting with 4 weeks experience of both MAPS Participants receiving both Categorical Loudness Scaling Based Fitting and behavioural fitting. Categorical loudness scaling based fitting using the Nexus Research System. Participants will receive a categorical loudness scaling based fitting (Interventional) and behavioural fitting with 4 weeks experience of both MAPS
- Primary Outcome Measures
Name Time Method Change in Adaptive sentence in noise scores (S0N0 test setup) 2 days (In booth testing) To determine whether the Loudness Target (LT) MAP provides non-inferior speech understanding in noise compared to the Behavioural MAP. Adaptive sentence in noise scores (S0N0 test setup) averaged across the sessions at visit 4 and visit 5.
Change in Percentage of correct monosyllabic word scores in quiet (S0) at 50 dB SPL 2 days(In booth testing) To determine whether the Loudness Target (LT) MAP provides non-inferior speech understanding in quiet compared to the Behavioural MAP. Percentage of correct monosyllabic word scores in quiet (S0) at 50 dB SPL averaged across the sessions at visit 4 and visit 5. Higher the score better the outcome.
- Secondary Outcome Measures
Name Time Method Adaptive Digit Triplet Test (DTT) in noise scores One day (in clinic testing) To determine whether the LT MAP provides non-inferior speech understanding in noise compared to the Behavioural MAP early post activation. Digit triplets are presented adaptively at different SNRs to estimate a patient's Speech Reception Threshold for 50%-digit triplet identification and expressed as a dB SNR (SNR50). The SRT is determined at the end of the test. A higher SRT means a worse outcome
Speech, Spatial and Qualities of Hearing Scale (SSQ12) ratings 4 weeks To determine whether the LT MAP provides non-inferior speech understanding, sound quality and spatial hearing performance subjective ratings in daily life compared to the Behavioural MAP.
The SSQ-12 is comprised of 12 items using the response format on a scale from 0 to 10, were 0 equals no ability and 10 equals perfect ability. These are divided into three sub-scales and the questions 1-5 are from the speech sub-scale, 6-8 from the spatial, and 9-12 from the qualities sub-scale. The three sub-scales are the average of the questions within. A 'not applicable' option is given for each item.
The change between LT to Behavioural MAP is then calculated and the theoretical score could vary between -10 to + 10. The higher the score the better benefit and positive score indicates improved hearing, a negative value an impaired hearing.Percentage correct monosyllabic word scores in quiet (S0) at 60 dB SPL One day (in booth testing) To determine whether the LT MAP provides non-inferior speech understanding in quiet compared to the Behavioural MAP early post activation.
Trial Locations
- Locations (4)
Cochlear Americas
🇺🇸Lone Tree, Colorado, United States
HEARnet
🇦🇺Carlton, Victoria, Australia
Cochlear Sydney
🇦🇺Sydney, Australia
Medizinische Hochschule Hannover (MHH)
🇩🇪Hannover, Germany